Enjoying this content?
Get three under-the-radar investment themes delivered to your inbox every Monday.
Investment Themes of the Week — March 16, 2026
Theme 1: EPA Biofuel Quota Increase Shifts Feedstock Economics for Renewable Fuel Producers
The proposed quota increase represents the most aggressive biofuel mandate expansion in recent years, creating guaranteed demand growth at a time when feedstock economics have shifted favorably. With biomass-based diesel quotas nearly doubling over two years, companies with existing refining capacity and secured feedstock supply chains are positioned to capture both volume growth and margin expansion.
The convergence of regulatory support and improved input economics creates a compelling setup for domestic producers. The EPA's long-term commitment reduces regulatory uncertainty that has historically pressured sector valuations, while the structural shift in the palm oil-gasoil spread means biofuel refiners can now secure feedstock at economically attractive levels while benefiting from higher mandated output volumes.
Supply dynamics also favor existing producers over new entrants. The capital-intensive nature of biofuel refining and the complexity of securing long-term feedstock contracts creates meaningful barriers to entry, benefiting established operators with proven infrastructure and supplier relationships already in place.
Stocks that would benefit:
GPRE: Green Plains Inc. - Operates the largest ethanol production platform in North America with integrated protein and renewable diesel capabilities, directly positioned to benefit from the EPA's proposed quota expansion. The company has been actively transforming its business model toward higher-margin renewable products, with its Ultra-High Protein and corn oil operations providing diversified revenue streams beyond ethanol alone. The biomass-based diesel quota increase to 5.61 billion gallons creates incremental demand for Green Plains' renewable diesel infrastructure, while its existing feedstock procurement network provides cost advantages over new market entrants. Read More →
GEVO: Gevo Inc. - Focuses on sustainable aviation fuel and renewable gasoline with established feedstock partnerships, making it a direct beneficiary of the EPA's biofuel mandate expansion across multiple fuel categories. Gevo's Net-Zero 1 plant in South Dakota is designed to produce sustainable aviation fuel from agricultural feedstocks, a category covered under the expanding biofuel quotas. The company's long-term offtake agreements with airlines and other fuel buyers provide revenue visibility that complements the regulatory certainty created by multi-year EPA quota commitments. Read More →
AMTX: Aemetis Inc. - Runs integrated biorefining operations with renewable diesel and sustainable aviation fuel production in California and India, positioned to capture the premium pricing that California's Low Carbon Fuel Standard adds on top of federal renewable fuel standards. Aemetis benefits from a dual compliance premium as both federal RFS mandates and California LCFS requirements create layered demand for its low-carbon fuel outputs. The company's agricultural waste feedstock strategy aligns with the EPA's preference for next-generation biofuels under the expanded quota framework. Read More →
Theme 2: Global Dairy Supply Tightening After Extended Decline Creates Recovery Setup
Regional supply constraints are becoming increasingly apparent across major producing areas. European butter prices have strengthened on retail demand ahead of spring holidays, while Oceania producers face tight near-term availability as the milking season progresses. The production slowdown is structural rather than temporary, with expected declines in South America, Australia, and China, while European milk production is forecast to decline 0.9% with impacts becoming more visible through the remainder of 2026.
The supply-demand rebalancing comes after an extended period of oversupply that pressured margins throughout the dairy value chain. Skim milk powder prices have firmed amid steady regional demand, and cheddar cheese prices strengthened on firm global demand. The psychological shift among market participants who are seeing prices move higher again after months of declines suggests the recovery has momentum beyond immediate supply constraints.
From an investment standpoint, the extended downturn has already compressed valuations across the dairy sector, meaning the recovery captures companies at historically attractive levels. Companies with direct commodity exposure benefit from operating leverage as prices recover, while downstream processors benefit from improved supply chain predictability and stabilizing input costs.
Stocks that would benefit:
LWAY: Lifeway Foods - The leading U.S. producer of kefir and probiotic dairy products operates as a pure-play dairy company with direct exposure to both dairy commodity costs and the growing functional food market. As the dominant player in the U.S. kefir category with over 95% market share, Lifeway benefits from recovering dairy input prices through improved margins while its premium positioning allows for pricing power. The company's international expansion into new markets provides additional growth levers that extend the recovery thesis beyond purely domestic commodity dynamics. Read More →
CALM: Cal-Maine Foods - The largest egg producer in the U.S. benefits from recovering dairy and broader agricultural protein complex pricing, as its feed cost structure is closely tied to the same commodity cycles affecting dairy markets. When dairy commodity prices recover, it signals broader agricultural market normalization that typically benefits protein producers across categories. Cal-Maine's financial strength, with a history of substantial dividend payments during commodity upcycles, positions it to return value to shareholders as margins improve through the recovery. Read More →
MDLZ: Mondelez International - As a major consumer of dairy ingredients across its global snacking portfolio, Mondelez benefits directly from supply chain stabilization and more predictable input costs as dairy markets recover from their oversupply cycle. The company's significant exposure to butter, milk powder, and cheese ingredients means that supply tightening translating into price stability removes a key earnings headwind. Mondelez's pricing power in branded consumer goods also allows it to maintain margins as input costs normalize rather than spike. Read More →
Theme 3: Medicare Telehealth Extension Removes Regulatory Overhang for Virtual Care
The Medicare coverage extension represents a critical inflection point for telehealth adoption, as reimbursement uncertainty had been the primary barrier to widespread provider adoption and patient access. Market forecasts project the digital obesity health market reaching $14 billion, reflecting demand for virtual weight-management and GLP-1 support services. The successful fundraising activity in mental health and women's health demonstrates investor confidence in targeted virtual care models.
Virtual care has moved beyond pandemic-driven necessity to become an integrated component of healthcare delivery. The regulatory stability provided by Medicare coverage extension allows providers to make long-term technology investments and care delivery commitments without the risk that reimbursement structures could change abruptly. This certainty is particularly valuable for companies that depend on Medicare enrollment, which continues growing as baby boomers age into eligibility.
The ongoing shortage of in-person healthcare providers, particularly specialists, creates structural demand for virtual alternatives that cannot be solved quickly through traditional means. Telehealth platforms that can scale specialist access without geographic constraints effectively expand healthcare supply in markets where physical capacity is constrained, creating durable competitive advantages for established platforms with broad provider networks.
Stocks that would benefit:
TDOC: Teladoc Health - Operates the largest integrated virtual care platform with comprehensive Medicare coverage across mental health, primary care, and chronic disease management, making it the primary beneficiary of expanded Medicare telehealth reimbursement. The company's BetterHelp mental health platform and chronic care management programs address the highest-demand categories in virtual care, while its established payer relationships provide a distribution advantage as Medicare coverage becomes permanent. Teladoc's scale allows it to invest in AI-assisted care delivery that improves outcomes while reducing per-visit costs, a critical factor for sustainable margins in a reimbursement-driven model. Read More →
AMWL: American Well - Provides telehealth infrastructure and direct care services to health systems and payers, benefiting as hospital and insurance clients expand virtual care programs under guaranteed Medicare coverage. Amwell's B2B model means it captures value as healthcare organizations build permanent telehealth infrastructure rather than temporary solutions, with recurring technology licensing revenue providing more predictable cash flows than direct patient care models. The Medicare extension gives Amwell's health system clients the confidence to make multi-year virtual care investments on the Amwell platform. Read More →
HIMS: Hims & Hers Health - A direct-to-consumer telehealth platform focused on specialty care categories including sexual health, mental health, and weight management that benefits from expanded insurance coverage as Medicare and commercial payers increase telehealth reimbursement. The company's compounding pharmacy capabilities and GLP-1 weight management programs are particularly well-positioned as the Medicare telehealth extension supports long-term chronic disease management programs. Hims & Hers has demonstrated strong revenue growth and improving unit economics as it scales its subscription-based care model across its addressable market. Read More →
Join our Discord community to give feedback, request features, or ask questions about the newsletter or website.
https://discord.gg/yePwyWrwJBThe content is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk. Past performance is not indicative of future results. Investments may lose value and are not guaranteed.
Loading more newsletters...
